However, it is reported that PRMT5 protein expression remains comparable among normal mammary epithelial cells, luminal breast cancer cells, and aggressive triple-negative breast cancer cells (TNBCs) [26]. This evidence concerns the gene PRMT5 and triple-negative breast carcinoma.